Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients.

Pharmaceuticals (Basel) · 2026 · PMC13028775 · PMID 41901359

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.582not close (p > 0.1)

showed a trendno p-value reported

In the unadjusted analysis, patients with a high PGx burden showed a trend toward a higher risk of composite adverse outcomes; however, this did not reach statistical significance (OR = 1.08; 95% CI: 0.82–1.42; p = 0.582). 2.5.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.